Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Synthetic Protein Could Be Used to Make Artificial Blood

By LabMedica International staff writers
Posted on 16 Apr 2009
Using design and engineering principles learned from nature, a team of biochemists has constructed--from scratch--an entirely new type of protein. More...


Most proteins are "large" and full of interdependent branches, bends, and pockets in their final folded structure. This complexity aggravates biochemists and protein engineers trying to understand protein structure and function in order to reproduce or create new uses for these natural molecules to combat diseases or for use in industry.

The new type of protein can transport oxygen, similar to human neuroglobin, a molecule that carries oxygen in the brain and peripheral nervous system. In the future, this approach could be used to make artificial blood for use on the battlefield or by emergency-care professionals. The study's findings were published in the March 19, 2009, issue of the journal Nature.

"This is quite a different way of making novel proteins than the rest of the world," stated senior author P. Leslie Dutton, Ph.D., professor of biochemistry and biophysics at the University of Pennsylvania School of Medicine (Penn; Philadelphia, USA). "We've created an unusually simple and relatively small protein that has a function, which is to carry oxygen. No one else has ever done this before."

"Our aim is to design new proteins from principles we discover studying natural proteins," explained coauthor Christopher C. Moser, Ph.D., associate director of the Johnson Foundation at Penn. "For example, we found that natural proteins are complex and fragile and when we make new proteins we want them to be simple and robust. That's why we're not reengineering a natural protein, but making one from scratch."

Currently, protein engineers take an existing biochemical scaffold from nature and change it a bit structurally to make it do something else. "This research demonstrates how we used a set of simple design principles, which challenge the kind of approaches that have been used to date in reproducing natural protein functions," said Dr. Dutton.

The natural design of proteins ultimately lies in their underlying sequence of amino acids; organic compounds that link together to make proteins. In living organisms, this sequence is dictated by the genetic information carried in DNA within chromosomes. This information is then encoded in messenger RNA, which is transcribed from DNA in the nucleus of the cell. The sequence of amino acids for a specific protein is determined by the sequence of nucleotides in messenger RNA. It is the order of the amino acids and the chemical bonds between them that determine how a protein folds into its final shape.

To build their protein, the Penn researchers began with just three amino acids, which code for a helix-shaped column. From this, they assembled a four-column bundle with a loop that resembles a simple candelabrum. They added a heme, a chemical group that contains an iron atom, to bind oxygen molecules. They also added another amino acid called glutamate to add strain to the candelabra to help the columns open up to capture the oxygen. Since heme and oxygen degrade in water, the researchers also designed the exteriors of the columns to deter water to protect the oxygen payload inside.

At first, the team used a synthesizer--a robot that chemically sticks amino acids together in a desired sequence--to make the helix-shaped columns. "We do the first reactions with the robot to figure out the sequence of amino acids that we want," stated Dr. Moser. When they were satisfied with the sequence, they used the bacterium Escherichia coli as a biologic host to make the full protein.

The scientists used chemical tests to validate that their protein did indeed capture oxygen. When the oxygen did bind to the iron heme molecule in the artificial protein, the solution in which the reaction occurred changed color from dark red to scarlet, a color signature almost identical to natural neuroglobin. "This exercise is like making a bus," said Dr. Dutton. "First you need an engine and we've produced an engine. Now we can add other things on to it. Using the bound oxygen to do chemistry will be like adding the wheels. Our approach to building a simple protein from scratch allows us to add on, without getting more and more complicated."

Related Links:

University of Pennsylvania School of Medicine




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.